公司資料
Teleflex 股價、新聞與催化劑
- 股票代碼:
- TFX
- 交易所:
- NYSE
- 產業:
- MedTech
- 所在地:
- United States
股票表現
126.11 USD (+0.86%)
收盤價
最後更新: 2026年10月1日
5.54B USD
市值
股價為何變動
截至 2026年10月1日，TFX 上漲 0.86%，收於 $126.11。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Diversified Medical Technology Company
Teleflex develops medical devices used in vascular access, interventional cardiology and radiology, surgery, anesthesia, emergency medicine, and urology. Its portfolio includes established brands such as Arrow, QuikClot, LMA, Weck, Barrigel, and Rüsch.
Vascular and Emergency Medicine
The vascular business includes central venous access, arterial access, intraosseous access, hemostatic products, and emergency-care technologies. EZPLAZ freeze-dried plasma extends the portfolio into a biologic product intended for settings where conventional plasma may be unavailable.
Interventional Portfolio
Teleflex's interventional business includes coronary and peripheral devices, catheter-based technologies, and the acquired BIOTRONIK vascular intervention portfolio. These products are used by interventional cardiologists and radiologists in minimally invasive procedures.
Surgical Products
The surgical portfolio includes ligation, closure, specialty instruments, and other products used in operating rooms. Brands such as Weck and Deknatel provide recurring demand across a broad range of procedures.
Freesolve Resorbable Scaffold
Freesolve is a drug-eluting resorbable magnesium scaffold designed to provide temporary vessel support and then dissolve. The program includes completed long-term follow-up, an ex-U.S. randomized study, and a U.S. pivotal trial.
未來催化劑
- Late-2027 data readout from the randomized BIOMAG-II study of the Freesolve resorbable magnesium scaffold.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。